These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 3742601)
1. The membrane phenotype of in vivo induced tumor selective cytolytic lymphocytes of the rat: a distinction from NK cells. Hedlund G; Sjögren HO Cell Immunol; 1986 Jun; 100(1):232-8. PubMed ID: 3742601 [TBL] [Abstract][Full Text] [Related]
2. Selective induction of OX19+ (CD5+) or OX19- (CD5-) alloreactive cytolytic lymphocytes in the rat. Hedlund G; Brodin T; Sjögren HO Cell Immunol; 1987 Apr; 105(2):366-73. PubMed ID: 3494529 [TBL] [Abstract][Full Text] [Related]
3. Phenotype of rat natural killer cells defined by monoclonal antibodies marking rat lymphocyte subsets. Cantrell DA; Robins RA; Brooks CG; Baldwin RW Immunology; 1982 Jan; 45(1):97-103. PubMed ID: 7056570 [TBL] [Abstract][Full Text] [Related]
4. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells. Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412 [TBL] [Abstract][Full Text] [Related]
5. A comparison of membrane markers on rat cytotoxic cells. Cantrell DA; Robins RA; Baldwin RW Immunology; 1983 May; 49(1):139-46. PubMed ID: 6220963 [TBL] [Abstract][Full Text] [Related]
6. Allogeneic lymphocyte cytotoxicity (ALC) in rats: establishment of an in vitro assay, and direct evidence that cells with natural killer (NK) activity are involved in ALC. Rolstad B; Fossum S Immunology; 1987 Feb; 60(2):151-7. PubMed ID: 2434415 [TBL] [Abstract][Full Text] [Related]
7. Spontaneous diabetes mellitus in the Bio-Breeding/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells. MacKay P; Jacobson J; Rabinovitch A J Clin Invest; 1986 Mar; 77(3):916-24. PubMed ID: 3512604 [TBL] [Abstract][Full Text] [Related]
8. Expression of T cell differentiation antigens and Ia on rat cytotoxic T lymphocytes. Duarte AJ; Carpenter CB; Strom TB J Immunol; 1982 Feb; 128(2):580-4. PubMed ID: 6976382 [TBL] [Abstract][Full Text] [Related]
10. Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells. Vujanovic NL; Herberman RB; Maghazachi AA; Hiserodt JC J Exp Med; 1988 Jan; 167(1):15-29. PubMed ID: 3257251 [TBL] [Abstract][Full Text] [Related]
11. Membrane phenotype of the rat cytotoxic T lymphocyte. Gilman SC; Rosenberg JS; Feldman JD J Immunol; 1982 Sep; 129(3):1012-6. PubMed ID: 6980913 [TBL] [Abstract][Full Text] [Related]
12. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. Lanier LL; Le AM; Phillips JH; Warner NL; Babcock GF J Immunol; 1983 Oct; 131(4):1789-96. PubMed ID: 6225799 [TBL] [Abstract][Full Text] [Related]
13. Separation and isolation of rat natural killer (NK) cells from T cells with monoclonal antibodies. Woda BA; McFadden ML; Welsh RM; Bain KM J Immunol; 1984 May; 132(5):2183-4. PubMed ID: 6609190 [TBL] [Abstract][Full Text] [Related]
14. Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. Like AA; Biron CA; Weringer EJ; Byman K; Sroczynski E; Guberski DL J Exp Med; 1986 Oct; 164(4):1145-59. PubMed ID: 3531381 [TBL] [Abstract][Full Text] [Related]
15. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells. Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622 [TBL] [Abstract][Full Text] [Related]
16. Characterization of human large granular lymphocyte subpopulations: comparison of the phenotype of NK cells and of interleukin 2-dependent progenitors of cytolytic effector cells. Allavena P; Klein R; Ortaldo JR Nat Immun Cell Growth Regul; 1985; 4(1):7-20. PubMed ID: 3875792 [TBL] [Abstract][Full Text] [Related]
18. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones. van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399 [TBL] [Abstract][Full Text] [Related]